joel parker - prediction of enzalutamide sensitivity in triple negative breast cancer
Published 7 years ago • 303 plays • Length 48:39Download video MP4
Download video MP3
Similar videos
-
1:52
traina: phase ii enzalutamide results in triple-negative breast cancer
-
1:59
the role of enzalutamide in hr advanced breast cancer
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
15:01
an end to one-size-fits-all cancer therapies
-
2:19
arb: preoperative treatment with enzalutamide in er and tnbc
-
5:28
evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...
-
1:32
suzanne a. w. fuqua, phd, discusses the androgen receptor in breast cancer
-
2:22
dr. dent discusses ipatasertib in triple-negative breast cancer
-
4:48
ar triple negative breast cancer clinical trial
-
1:42
dr. yardley discusses enzalutamide in hr breast cancer
-
4:11
potential evolutions in the tnbc treatment paradigm
-
1:24
oligometastatic diseases (omd) in breast cancer
-
8:05
keynote-522: immune therapy and chemotherapy in patients with early triple negative breast cancer
-
3:32
targeted therapies for triple-negative breast cancer
-
6:57
what is tnbc (triple negative breast cancer)
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
4:19
2020 pelotonia idea grant: immune checkpoint blockade therapy for triple-negative breast cancer
-
1:54
novel agents for neoadjuvant tnbc treatment